Skip to main content
Clinical Trials/ISRCTN18383298
ISRCTN18383298
Completed
未知

Multicentre, randomised, open clinical trial to assess the efficacy of an intervention to reduce the cardiovascular risk by improving the information given to patients at high cardiovascular risk

Biomedical Research Institute Sant Pau0 sites464 target enrollmentFebruary 6, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
People at high cardiovascular risk
Sponsor
Biomedical Research Institute Sant Pau
Enrollment
464
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

2021 results in https://pubmed.ncbi.nlm.nih.gov/33807285/ (added 17/06/2021)

Registry
who.int
Start Date
February 6, 2018
End Date
December 31, 2019
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Biomedical Research Institute Sant Pau

Eligibility Criteria

Inclusion Criteria

  • 1\. Both gender
  • 2\. 40\- 69 years old
  • 3\. Fulfilling at least one of the following criteria
  • 3\.1\. High cardiovascular risk (SCORE \=5% and/or REGICOR \=10%)
  • 3\.2\. SCORE relative risk \>\= 4
  • 3\.3\. Diabetes with proteinuria or a major risk factor (smoking, dyslipidaemia or hypertension)
  • 4\. Severe kidney chronic disease (GFR \< 30 mL/min/1\.73 m2\)
  • 5\. Subclinical Atherosclerosis

Exclusion Criteria

  • 1\. Patients with established cardiovascular disease
  • 2\. Life expectancy of less than 1 year
  • 3\. Mental disease limiting patient’s self\-care capability
  • 4\. Drug and/or alcohol abuse
  • 5\. Already enrolled in another clinical trial

Outcomes

Primary Outcomes

Not specified

Similar Trials